129 related articles for article (PubMed ID: 18382925)
21. PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated.
Leo E; Ruozi B; Tosi G; Vandelli MA
Int J Pharm; 2006 Oct; 323(1-2):131-8. PubMed ID: 16815657
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of novel polyester-ibuprofen conjugates for modified drug release.
Thompson CJ; Hansford D; Munday DL; Higgins S; Rostron C; Hutcheon GA
Drug Dev Ind Pharm; 2008 Aug; 34(8):877-84. PubMed ID: 18622877
[TBL] [Abstract][Full Text] [Related]
23. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
[TBL] [Abstract][Full Text] [Related]
24. Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement.
Castellanos IJ; Griebenow K
Pharm Res; 2003 Nov; 20(11):1873-80. PubMed ID: 14661935
[TBL] [Abstract][Full Text] [Related]
25. Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.
Brunner CT; Baran ET; Pinho ED; Reis RL; Neves NM
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):498-507. PubMed ID: 21376545
[TBL] [Abstract][Full Text] [Related]
26. Encapsulation-induced aggregation and loss in activity of gamma-chymotrypsin and their prevention.
Castellanos IJ; Cruz G; Crespo R; Griebenow K
J Control Release; 2002 Jun; 81(3):307-19. PubMed ID: 12044569
[TBL] [Abstract][Full Text] [Related]
27. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
28. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
[TBL] [Abstract][Full Text] [Related]
30. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
31. Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres.
Castellanos IJ; Crespo R; Griebenow K
J Control Release; 2003 Feb; 88(1):135-45. PubMed ID: 12586511
[TBL] [Abstract][Full Text] [Related]
32. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination.
Giunchedi P; Conti B; Scalia S; Conte U
J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429
[TBL] [Abstract][Full Text] [Related]
33. Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres.
Li X; Zhang Y; Yan R; Jia W; Yuan M; Deng X; Huang Z
J Control Release; 2000 Jul; 68(1):41-52. PubMed ID: 10884578
[TBL] [Abstract][Full Text] [Related]
34. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study.
Jameela SR; Suma N; Jayakrishnan A
J Biomater Sci Polym Ed; 1997; 8(6):457-66. PubMed ID: 9151193
[TBL] [Abstract][Full Text] [Related]
35. Development of poly(glycerol adipate) nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Wahab A; Favretto ME; Onyeagor ND; Khan GM; Douroumis D; Casely-Hayford MA; Kallinteri P
J Microencapsul; 2012; 29(5):497-504. PubMed ID: 22769722
[TBL] [Abstract][Full Text] [Related]
36. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
37. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.
Ruan G; Feng SS; Li QT
J Control Release; 2002 Dec; 84(3):151-60. PubMed ID: 12468218
[TBL] [Abstract][Full Text] [Related]
38. Fabrication of microspheres using blends of poly(ethylene adipate) and poly(ethylene adipate)/poly(hydroxybutyrate-hydroxyvalerate) with poly(caprolactone): incorporation and release of bovine serum albumin.
Atkins TW
J Biomater Sci Polym Ed; 1997; 8(11):833-45. PubMed ID: 9342650
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
Zhang XQ; Intra J; Salem AK
J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
[TBL] [Abstract][Full Text] [Related]
40. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity.
Murillo M; Gamazo C; Irache JM; Goñi MM
J Drug Target; 2002 May; 10(3):211-9. PubMed ID: 12075822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
